Note 17 - Parent Company Financial Information (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Notes Tables |
|
| Condensed Balance Sheet [Table Text Block] |
|
Balance Sheets
|
|
|
(Dollars in thousands)
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
2025
|
|
|
2024
|
|
| |
|
|
|
|
|
|
|
|
|
Assets
|
|
| |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
500 |
|
|
$ |
19 |
|
|
Investment in subsidiaries
|
|
|
76,348 |
|
|
|
67,644 |
|
|
Other assets
|
|
|
153 |
|
|
|
125 |
|
| |
|
$ |
77,001 |
|
|
$ |
67,788 |
|
| |
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity
|
|
| |
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
$ |
12,036 |
|
|
$ |
11,329 |
|
|
Accrued interest payable
|
|
|
262 |
|
|
|
119 |
|
|
Other liabilities
|
|
|
43 |
|
|
|
68 |
|
| |
|
|
12,341 |
|
|
|
11,516 |
|
|
Stockholders' equity
|
|
|
|
|
|
|
|
|
|
Common stock, par value $.01 per share, authorized 5,000,000 shares; issued and outstanding 3,229,795 in 2025 and 3,166,653 in 2024
|
|
|
32 |
|
|
|
32 |
|
|
Additional paid-in capital
|
|
|
32,148 |
|
|
|
31,136 |
|
|
Retained earnings
|
|
|
45,210 |
|
|
|
41,613 |
|
|
Accumulated other comprehensive loss
|
|
|
(12,730 |
) |
|
|
(16,509 |
) |
| |
|
|
64,660 |
|
|
|
56,272 |
|
| |
|
$ |
77,001 |
|
|
$ |
67,788 |
|
|
| Condensed Income Statement [Table Text Block] |
|
Statements of Income
|
|
|
(Dollars in thousands)
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
2025
|
|
|
2024
|
|
| |
|
|
|
|
|
|
|
|
|
Income
|
|
|
|
|
|
|
|
|
|
Cash dividends from subsidiaries
|
|
$ |
1,434 |
|
|
$ |
3,598 |
|
|
Total income
|
|
|
1,434 |
|
|
|
3,598 |
|
| |
|
|
|
|
|
|
|
|
|
Interest expense - long-term debt
|
|
|
(600 |
) |
|
|
(508 |
) |
|
Noninterest expense
|
|
|
(147 |
) |
|
|
(92 |
) |
| |
|
|
|
|
|
|
|
|
|
Income before income taxes and equity in undistributed income of subsidiaries
|
|
|
687 |
|
|
|
2,998 |
|
|
Income tax benefit
|
|
|
(153 |
) |
|
|
(125 |
) |
|
Income before equity in undistributed income of subsidiaries
|
|
|
840 |
|
|
|
3,123 |
|
|
Dividends in excess of income of insurance subsidiary
|
|
|
- |
|
|
|
- |
|
|
Equity in undistributed income of insurance subsidiary
|
|
|
- |
|
|
|
- |
|
|
Equity in undistributed income of bank subsidiary
|
|
|
4,926 |
|
|
|
1,155 |
|
|
Net Income
|
|
$ |
5,766 |
|
|
$ |
4,278 |
|
|
| Condensed Cash Flow Statement [Table Text Block] |
|
(Dollars in thousands)
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
2025
|
|
|
2024
|
|
| |
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
Net Income
|
|
$ |
5,766 |
|
|
$ |
4,278 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
Equity in undistributed income of subsidiaries
|
|
|
(4,926 |
) |
|
|
(1,155 |
) |
|
Increase (Decrease) in accrued interest payable
|
|
|
144 |
|
|
|
(20 |
) |
|
Amortization of debt issuance costs
|
|
|
16 |
|
|
|
6 |
|
|
Stock based compensation
|
|
|
172 |
|
|
|
18 |
|
|
Change in income tax receivable
|
|
|
(28 |
) |
|
|
20 |
|
|
(Decrease) Increase in other liabilities
|
|
|
(25 |
) |
|
|
68 |
|
|
Cash provided by operating activities
|
|
|
1,119 |
|
|
|
3,215 |
|
| |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
Cash used in investing activities
|
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
Subordinated debt offering, net of issuance costs
|
|
|
12,024 |
|
|
|
- |
|
|
Long-term debt principal payments
|
|
|
(11,333 |
) |
|
|
(1,889 |
) |
|
Dividends paid, net of reinvestments
|
|
|
(1,329 |
) |
|
|
(1,377 |
) |
|
Cash used in financing activities
|
|
|
(638 |
) |
|
|
(3,266 |
) |
| |
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
481 |
|
|
|
(51 |
) |
| |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
19 |
|
|
|
70 |
|
|
Cash and cash equivalents at end of period
|
|
$ |
500 |
|
|
$ |
19 |
|
|